EcoDrugPlus

Phosphodiesterase 10a

Ensembl ID : ENSOMYG00000018486
Gene Symbol: PDE10A
1 Cross references
200 Possible Orthologues:

Phosphodiesterase 10a

Ensembl ID : ENSOMYG00000056489
Gene Symbol: PDE10A
1 Cross references
200 Possible Orthologues:

Phosphodiesterase 3a

Ensembl ID : ENSOMYG00000033100
Gene Symbol: PDE3A
1 Cross references
207 Possible Orthologues:

Phosphodiesterase 3a

Ensembl ID : ENSOMYG00000000190
Gene Symbol: PDE3A
1 Cross references
198 Possible Orthologues:

Phosphodiesterase 3a

Ensembl ID : ENSOMYG00000044522
Gene Symbol: PDE3A
1 Cross references
209 Possible Orthologues:

Phosphodiesterase 3b

Ensembl ID : ENSOMYG00000028505
Gene Symbol: PDE3B
1 Cross references
211 Possible Orthologues:

Phosphodiesterase 3b

Ensembl ID : ENSOMYG00000038397
Gene Symbol: PDE3B
1 Cross references
210 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSOMYG00000005796
Gene Symbol: PDE4B
1 Cross references
218 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSOMYG00000000343
Gene Symbol: PDE4B
1 Cross references
218 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSOMYG00000026316
Gene Symbol: PDE4B
1 Cross references
219 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSOMYG00000044952
Gene Symbol: PDE4B
1 Cross references
219 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSOMYG00000027275
Gene Symbol: PDE4D
1 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).